CD4 and HIV infectious disease: To characterize the effect of ADAM inhibition on HIV infection, we performed transcriptome analysis by high throughput RNAseq using Illumina platform (Novogene Co. Ltd.)on HIV-1BAL infected with and without BB-94 treatment as well as uninfected CD4 T cells on day 6 post infection (Table 3).